February 2017 – Policy & Medicine

Trump Executive Order Targets Regulations

Qordata Hosting Compliance Insights Webinar March 1

Senate Finance Committee Hearing on Seema Verma Confirmation

FDA’s Meeting on Promotion – Can We Glimpse the Future?

Medical Device Parallel Review Program Made Permanent

Are the Safe Harbors Still Safe? – OIG Issues Final Rule

Providers May Have More Time to Submit Electronic Clinical Quality Measures

Citizens Petition Challenges FDA’s Off-Label Rule

Valeant and Philidor Controversy Comes to a Head

CMS Releases Report to Congress on CMMI